IB Acquisition Corp（IBAC）股票分析

AI 分析 of IB Acquisition Corp (IBAC)

卖出

IB Acquisition Corp is not a good buy right now due to significant financial struggles and negative momentum. The current price is $10.81, with a 52-week high of $11.64, indicating it is near the lower end of its range. The RSI is at 20.283, which suggests it is oversold, but this could indicate a continued downward trend rather than a buying opportunity. Additionally, the company has reported negative net income in the last three quarters, with a loss of $639,866 in Q2 2026, raising concerns about its financial health.

估值指标

IB Acquisition Corp（IBAC）当前预期市盈率为 0.00，5 年平均预期市盈率为 0.00。

预期市盈率

严重低估

5 年均值 P/E

0.00

当前P/E

0.00

高估

0.00

低估

0.00

预期 EV/EBITDA

严重低估

5 年均值 EV/EBITDA

0.00

当前EV/EBITDA

0.00

高估

0.00

低估

0.00

预期市销率

合理

5 年均值 P/S

0.06

当前P/S

0.00

高估

0.83

低估

-0.72

Alphio AI 对 IBAC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重（25 / 50 / 25），不构成保证。

乐

乐观

乐观 · 25%IBAC

$11.75

情景价格

基

基准

基准 · 50%IBAC

$10.62

情景价格

悲

悲观

悲观 · 25%IBAC

$10.48

情景价格

IBAC 常见问题 —— 由 Alphio AI 解答

IB Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the Business Combination). It intends to focus on pursuing an acquisition of or merger with high-growth companies in a number of industries including but not limited to fintech, healthcare and life sciences, sports and entertainment, and consumer goods. The Company anticipates targeting companies domiciled in North America, Europe and Asia, with an enterprise value of at least $500 million. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.

IB Acquisition Corp is not a good buy right now due to significant financial struggles and negative momentum. The current price is $10.81, with a 52-week high of $11.64, indicating it is near the lower end of its range. The RSI is at 20.283, which suggests it is oversold, but this could indicate a continued downward trend rather than a buying opportunity. Additionally, the company has reported negative net income in the last three quarters, with a loss of $639,866 in Q2 2026, raising concerns about its financial health.